Dec 01, 2020 / 04:20PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MD
Okay. Thanks, everyone, for joining us. I guess it's still morning, it's not yet the afternoon. I'm Vijay Kumar, the life science and device analyst at Evercore. A pleasure to have with us the original backstreet boys. We have Jay Saccaro, the CFO from Baxter, the CFO; and from IR, we have Clare Trachtman. Jay and Clare, thank you both for taking the time and spending some time with us this morning.
James K. Saccaro - Baxter International Inc. - Executive VP & CFO
Vijay, it's our pleasure. Nice to see you here virtually. Thanks for the interest in the company.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MDAt some point, hopefully, this virtual way will pass and we can meet in person. But on that optimistic note, I guess, Jay, maybe let's start with something which has been topical. I know I've been asking all the other device companies. What's been the impact from